TCL1 Predicts Time to Treatment in Chronic Lymphocytic Leukemia

被引：0
|
作者：
Ng, D. P.
Bennett, R. R.
Lansigan, F.
Levy, N. B.
Danilov, A. V.
Kaur, P.
机构：
[1] Dartmouth Hitchcock Med Ctr, Lebanon, NH 03766 USA
[2] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Hanover, NH 03756 USA
来源：
MODERN PATHOLOGY | 2012年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1501
引用
收藏
页码：357A / 357A
页数：1
相关论文
共 50 条
  • [31] Targeting the Adenosinergic Axis in the Eμ-TCL1 Chronic Lymphocytic Leukemia Mouse Model Offers Novel Therapeutic Opportunities
    Papait, Andrea
    Vaisitti, Tiziana
    Serra, Sara
    Audrito, Valentina
    Tito, Francesco
    Guerra, Giulia
    Efremov, Dimitar G.
    Deaglio, Silvia
    BLOOD, 2018, 132
  • [32] TCL1 expression in chronic lymphocytic leukemia correlates with the intensity of 11q deletions and ZAP-70
    Rassenti, Laura
    Huynh, L.
    Basak, G. W.
    Ghia, E. M.
    Dyke, D. Van
    Heerema, N.
    Zahrieh, D.
    DalCin, P.
    Dell'Aquila, M. L.
    Koduru, P.
    Byrd, J. C.
    Kay, N. E.
    Rai, K. R.
    Brown, J. R.
    Wierda, W. W.
    Greaves, A. W.
    Kipps, Thomas J.
    BLOOD, 2007, 110 (11) : 616A - 616A
  • [33] EXPRESSION OF FCGAMMARIIB PREDICTS TIME TO TREATMENT IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA
    Bosch, R.
    Vicente, E. P.
    Mora, A.
    Ferrer, G.
    Damle, R.
    Gorlatov, S.
    Rai, K.
    Montserrat, E.
    Nomdedeu, J.
    Blanco, L.
    Pratcorona, M.
    Delgado, J.
    Sierra, J.
    Chiorazzi, N.
    Moreno, C.
    HAEMATOLOGICA, 2016, 101 : 427 - 428
  • [34] Chronic lymphocytic leukemia disease progression is accelerated by APRIL-TACI interaction in the TCL1 transgenic mouse model
    Lascano, Valeria
    Guadagnoli, Marco
    Schot, Jan G.
    Luijks, Dieuwertje M.
    Guikema, Jeroen E. J.
    Cameron, Katherine
    Hahne, Michael
    Pals, Steven
    Slinger, Erik
    Kipps, Thomas J.
    van Oers, Marinus H. J.
    Eldering, Eric
    Medema, Jan Paul
    Kater, Arnon P.
    BLOOD, 2013, 122 (24) : 3960 - 3963
  • [35] Evidence for Non-Cancer-Specific T Cell Exhaustion in the Tcl1 Mouse Model for Chronic Lymphocytic Leukemia
    Parigger, Thomas
    Gassner, Franz Josef
    Scherhaeufl, Christian
    Abu Bakar, Aryunni
    Hoepner, Jan Philip
    Hoedlmoser, Alexandra
    Steiner, Markus
    Catakovic, Kemal
    Geisberger, Roland
    Greil, Richard
    Zaborsky, Nadja
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (13)
  • [36] Stromal cells modulate TCL1 expression, interacting AP-1 components and TCL1-targeting micro-RNAs in chronic lymphocytic leukemia
    M Sivina
    E Hartmann
    E Vasyutina
    J M Boucas
    A Breuer
    M J Keating
    W G Wierda
    A Rosenwald
    M Herling
    J A Burger
    Leukemia, 2012, 26 : 1812 - 1820
  • [37] Stromal cells modulate TCL1 expression, interacting AP-1 components and TCL1-targeting micro-RNAs in chronic lymphocytic leukemia
    Sivina, M.
    Hartmann, E.
    Vasyutina, E.
    Boucas, J. M.
    Breuer, A.
    Keating, M. J.
    Wierda, W. G.
    Rosenwald, A.
    Herling, M.
    Burger, J. A.
    LEUKEMIA, 2012, 26 (08) : 1812 - 1820
  • [38] MicroRNA 16-1 Predicts Time-to-Treatment (TTT) in Chronic Lymphocytic Leukemia
    Kaur, P.
    Steinmetz, H. B.
    Lefferts, C. L.
    Danilov, A. V.
    Tsongalis, G. J.
    MODERN PATHOLOGY, 2012, 25 : 346A - 346A
  • [39] MicroRNA 16-1 Predicts Time-to-Treatment (TTT) in Chronic Lymphocytic Leukemia
    Kaur, P.
    Steinmetz, H. B.
    Lefferts, C. L.
    Danilov, A. V.
    Tsongalis, G. J.
    LABORATORY INVESTIGATION, 2012, 92 : 346A - 346A
  • [40] In vivo application of the lipase inhibitor orlistat suppresses chronic lymphocytic leukemia (CLL) in an Eμ-TCL1 transgenic mouse model
    Pallasch, C. P.
    Schneider, P.
    Frenzel, L. P.
    Reinart, N.
    Taubert, D.
    Schwamb, J.
    Fingerle-Rowson, G.
    Wendtner, C-M
    ONKOLOGIE, 2010, 33 : 184 - 184
12345